Latest News

 Filter by Provider

Here's a look at the details in Fabrinet's Q1 earnings report.

Aerospace and defense company BWX (NYSE:BWXT) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 28.9% year on year to $866.3 million. On the other hand, the company’s full-year revenue guidance of $3.1 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $1 per share was 16.5% above analysts’ consensus estimates.

Online insurance comparison site EverQuote (NASDAQ:EVER) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 20.3% year on year to $173.9 million. On top of that, next quarter’s revenue guidance ($177 million at the midpoint) was surprisingly good and 9.9% above what analysts were expecting. Its GAAP profit of $0.50 per share was 30.6% above analysts’ consensus estimates.

The oil markets had a green day today.

Short-term technical indicator signals caution for buying stocks.

Tariffs can reshape the face of trade, making trade with certain countries or certain products more or less attractive. But the overall trade deficits is not caused by tariffs, or the lack of tariffs.

Energy and renewable energy projects company Ameresco (NYSE:AMRC) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 5% year on year to $526 million. On the other hand, the company’s full-year revenue guidance of $1.9 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.35 per share was 15.4% above analysts’ consensus estimates.

Digital casino game platform PlayStudios (NASDAQ:MYPS) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 19.1% year on year to $57.65 million. Its GAAP loss of $0.07 per share was significantly below analysts’ consensus estimates.

Civil infrastructure construction company Sterling Infrastructure (NASDAQ:STRL) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 16% year on year to $689 million. The company’s full-year revenue guidance of $2.38 billion at the midpoint came in 5.9% above analysts’ estimates. Its non-GAAP profit of $3.48 per share was 22.6% above analysts’ consensus estimates.

The following is a short list of some of the many stocks going ex-dividend during the next month.

Building products company Boise Cascade Company (NYSE:BCC) announced better-than-expected revenue in Q3 CY2025, but sales fell by 2.7% year on year to $1.67 billion. Its GAAP profit of $0.58 per share was 16.3% below analysts’ consensus estimates.

Infrastructure construction company Primoris (NYSE:PRIM) announced better-than-expected revenue in Q3 CY2025, with sales up 32.1% year on year to $2.18 billion. Its non-GAAP profit of $1.88 per share was 38.8% above analysts’ consensus estimates.

Cloud communications provider RingCentral (NYSE:RNG) met Wall Streets revenue expectations in Q3 CY2025, with sales up 4.9% year on year to $638.7 million. On the other hand, next quarter’s revenue guidance of $622 million was less impressive, coming in 3.8% below analysts’ estimates. Its non-GAAP profit of $1.13 per share was 5.2% above analysts’ consensus estimates.

Sarepta shares are plunging in extended trading Monday after the company reports third-quarter results and provided an update on its ESSENCE study.

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year revenue guidance of $3.23 billion at the midpoint came in 2.2% above analysts’ estimates. Its non-GAAP profit of $0.24 per share was 49.4% above analysts’ consensus estimates.

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Retail traders make decisions based on charts and past price action, while institutional money is positioning for what's about to happen.

Go-to-market intelligence provider ZoomInfo (NASDAQ:GTM) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $318 million. Guidance for next quarter’s revenue was better than expected at $308.5 million at the midpoint, 1.2% above analysts’ estimates. Its non-GAAP profit of $0.28 per share was 9.5% above analysts’ consensus estimates.

Medical products company UFP Technologies (NASDAQ:UFPT) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 6.5% year on year to $154.6 million. Its non-GAAP profit of $2.39 per share was 10% above analysts’ consensus estimates.

Industrial cleaning equipment manufacturer Tennant Company missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 4% year on year to $303.3 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.23 billion at the midpoint. Its non-GAAP profit of $1.46 per share was 2.9% below analysts’ consensus estimates.

HR outsourcing provider Insperity (NYSE:NSP) met Wall Streets revenue expectations in Q3 CY2025, with sales up 4% year on year to $1.62 billion. Its non-GAAP loss of $0.20 per share was significantly below analysts’ consensus estimates.

The S&P 500 Index ($SPX ) (SPY ) on Monday rose +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) fell -0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.37%. December E-mini S&P futures (ESZ25 ) rose +0.09%, and December E-mini...

Here's a look at the details in Upwork's Q3 earnings report.

Palantir broke records once again with its third-quarter earnings as the company's artificial-intelligence offerings drove aggressive business growth. 

Motion control and electronic systems manufacturer Helios Technologies (NYSE:HLIO) announced better-than-expected revenue in Q3 CY2025, with sales up 13.3% year on year to $220.3 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $197 million was less impressive, coming in 2.1% below expectations. Its non-GAAP profit of $0.72 per share was 9.8% above analysts’ consensus estimates.

Navitas reports financial results for the third quarter after the market close on Monday. Here are the key details from the report.

Consumer products giant Clorox (NYSE:CLX) announced better-than-expected revenue in Q3 CY2025, but sales fell by 18.9% year on year to $1.43 billion. Its non-GAAP profit of $0.85 per share was 9.2% above analysts’ consensus estimates.

Food processing and aviation equipment manufacturer John Bean (NYSE:JBT) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 121% year on year to $1.00 billion. The company’s full-year revenue guidance of $3.78 billion at the midpoint came in 1.9% above analysts’ estimates. Its non-GAAP profit of $1.94 per share was 28.9% above analysts’ consensus estimates.

Technical analysis of the charts of crude oil (WTI) and natural gas.

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11% year on year to $3.08 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $11.95 billion at the midpoint. Its non-GAAP profit of $4.80 per share was 4.9% above analysts’ consensus estimates.

Semiconductor manufacturer Magnachip Semiconductor (NYSE:MX) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 30.9% year on year to $45.95 million. On the other hand, next quarter’s revenue guidance of $40.5 million was less impressive, coming in 14.9% below analysts’ estimates. Its non-GAAP loss of $0.01 per share was 91.7% above analysts’ consensus estimates.

The artificial intelligence (AI) data center operator struck a blockbuster deal with Microsoft.

Employee benefits provider Unum Group (NYSE:UNM) announced better-than-expected revenue in Q3 CY2025, with sales up 4.6% year on year to $3.38 billion. Its non-GAAP profit of $2.09 per share was 2.7% below analysts’ consensus estimates.

Online work marketplace Upwork (NASDAQ:UPWK) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.1% year on year to $201.7 million. Guidance for next quarter’s revenue was better than expected at $195.5 million at the midpoint, 1.7% above analysts’ estimates. Its non-GAAP profit of $0.36 per share was 25.9% above analysts’ consensus estimates.

Retirement solutions provider Corebridge Financial (NYSE:CRBG) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $4.19 billion. Its non-GAAP profit of $0.96 per share was 11.4% below analysts’ consensus estimates.

Wellness company Medifast (NYSE:MED) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 36.2% year on year to $89.41 million. On the other hand, next quarter’s revenue guidance of $72.5 million was less impressive, coming in 1.8% below analysts’ estimates. Its GAAP loss of $0.21 per share was 41.7% above analysts’ consensus estimates.

Here's a look at the Q3 earnings report from Hims & Hers Health.

Professional staffing firm Kforce (NYSE:KFRC) announced better-than-expected revenue in Q3 CY2025, but sales fell by 5.9% year on year to $332.6 million. On top of that, next quarter’s revenue guidance ($330 million at the midpoint) was surprisingly good and 3% above what analysts were expecting. Its GAAP profit of $0.63 per share was 12.7% above analysts’ consensus estimates.

Healthcare services company The Ensign Group (NASDAQ:ENSG). beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 19.8% year on year to $1.30 billion. The company’s full-year revenue guidance of $5.06 billion at the midpoint came in 1% above analysts’ estimates. Its GAAP profit of $1.42 per share was 4.9% below analysts’ consensus estimates.

The Dow and Nasdaq moved in opposite directions to kick off November.

Insurance services company CNO Financial Group (NYSE:CNO) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 26.2% year on year to $1.19 billion. Its non-GAAP profit of $1.29 per share was 40.2% above analysts’ consensus estimates.

Medical technology company Hologic (NASDAQ:HOLX) announced better-than-expected revenue in Q3 CY2025, with sales up 6.2% year on year to $1.05 billion. Its non-GAAP profit of $1.13 per share was 2.7% above analysts’ consensus estimates.

Palantir reported third-quarter financial results after the market close on Monday. Here's a rundown of the report.